Stereotaxis Inc (STXS) Stock Price, Quote & News

Company Profile

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed t...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 314 678 6100

Website: www.stereotaxis.com

Address:

710 North Tucker Boulevard, Suite 110, Saint Louis, United States

brunoq14 Sep. 17 at 10:05 PM

$STXS At this rate if they ever report some decent sales the price might double.

0 · Reply

Eddypgil Sep. 17 at 12:33 PM

$STXS company has long awaited products, steadily growing revenue, cash in bank. It shouldn’t be trading for a $1.33! Market cap is $132 million.

0 · Reply

brunoq14 Sep. 16 at 4:55 PM

$STXS https://ir.stereotaxis.com/news-releases/news-release-details/stereotaxis-emerging-digital-ai-and-automation-capabilities-be

1 · Reply

TAE63 Sep. 16 at 1:10 PM

Liking $STXS , this week .

1 · Reply

Eddypgil Sep. 15 at 12:27 PM

$STXS too much going on with company to be at $1.33. The recent purchase of the French company behind price decline most likely

0 · Reply

PatVian Sep. 11 at 4:32 PM

$STXS Love the tech and potential. They are working on the catheter bottleneck as well. Could be explosive eventually, especially if upcoming data is strong 💪🏼

0 · Reply

Eddypgil Sep. 11 at 2:49 PM

$STXS they have a leasing program for GenesisX . No buildout needed. One would think they’d sell at least a half dozen in this quarter

0 · Reply

dman6 Sep. 11 at 12:49 AM

$STXS is there anyone here?? Zero chatter on this ticker

2 · Reply

Eddypgil Sep. 10 at 9:18 PM

$STXS does company have a talented sales team? They seem to have had great products approved over past year and few Genesis sales.

0 · Reply

Eddypgil Sep. 8 at 3:57 PM

$STXS ceo wouldn’t have made the acquisition of Robocath if he didn’t see strong future business in the pipeline. This could be a great time to buy possibly. First quarter sales could surprise

0 · Reply

Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society's HRX 2026

Sep 3, 2026, 7:56 AM EDT - 14 days ago

University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program

2026-08-27T09:55:19.000Z - 21 days ago

Stereotaxis price target lowered to $3 from $4 at Citizens

Aug 18, 2026, 8:50 AM EDT - 4 weeks ago

Stereotaxis Slides: Investor presentation

2026-08-17T09:31:44.000Z - 4 weeks ago

Stereotaxis price target lowered to $3 from $4 at Lake Street

2026-08-17T09:29:44.000Z - 4 weeks ago

Stereotaxis price target lowered to $3 from $5 at TD Cowen

Aug 11, 2026, 4:30 PM EDT - 5 weeks ago

Stereotaxis Earnings Call Transcript: Q2 2026

Aug 11, 2026, 4:30 PM EDT - 5 weeks ago

Stereotaxis Earnings release: Q2 2026

Aug 11, 2026, 4:30 PM EDT - 5 weeks ago

Stereotaxis Quarterly report: Q2 2026

2026-08-11T20:05:25.000Z - 5 weeks ago

Stereotaxis reports Q2 EPS (5c), consensus (5c)

Aug 11, 2026, 4:01 PM EDT - 5 weeks ago

Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates

Jul 21, 2026, 9:00 AM EDT - 1 month ago

Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026

Jul 20, 2026, 8:31 AM EDT - 1 month ago

University of Szeged Pioneers First Robotic Cardiology Program in Hungary

2026-07-15T21:30:19.000Z - 2 months ago

Stereotaxis files to sell 108.87M shares of common stock for holders

2026-07-15T21:25:18.000Z - 2 months ago

Stereotaxis files to sell 19.45M shares of common stock for holders

Jul 15, 2026, 8:00 AM EDT - 2 months ago

Stereotaxis Registration statement: Registration filing

Jul 15, 2026, 8:00 AM EDT - 2 months ago

Stereotaxis Registration statement: Registration filing

Jul 9, 2026, 8:08 AM EDT - 2 months ago

Stereotaxis Completes Acquisition of Robocath

2026-07-01T20:10:17.000Z - 2 months ago

Stereotaxis management to meet with BTIG

Jun 23, 2026, 7:00 AM EDT - 2 months ago

Stereotaxis Slides: Investor presentation

2026-05-13T11:19:51.000Z - 4 months ago

Stereotaxis price target lowered to $3.50 from $4 at Piper Sandler

JNJ

May 12, 2026, 4:30 PM EDT - 4 months ago

Stereotaxis Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 4 months ago

Stereotaxis Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 4 months ago

Stereotaxis Quarterly report: Q1 2026

May 12, 2026, 4:06 PM EDT - 4 months ago

Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates

Apr 22, 2026, 7:58 AM EDT - 4 months ago

Stereotaxis Announces First MAGiC Procedures in the United States

Apr 21, 2026, 9:01 AM EDT - 4 months ago

Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026

Apr 15, 2026, 9:00 AM EDT - 5 months ago

Stereotaxis Transcript: M&A announcement

Apr 15, 2026, 9:00 AM EDT - 5 months ago

Stereotaxis Press release: M&A announcement

2026-04-15T11:12:19.000Z - 5 months ago

Stereotaxis to acquire Robocath, terms undisclosed

Apr 15, 2026, 7:00 AM EDT - 5 months ago

Stereotaxis Announces Definitive Agreement to Acquire Robocath

2026-04-06T12:40:34.000Z - 5 months ago

Stereotaxis receives FDA clearance for Synchrony system

Apr 6, 2026, 8:06 AM EDT - 5 months ago

Stereotaxis Announces FDA Clearance and Launch of Synchrony System

Apr 3, 2026, 8:00 AM EDT - 5 months ago

Stereotaxis Proxy statement: Proxy filing

Apr 3, 2026, 8:00 AM EDT - 5 months ago

Stereotaxis Proxy statement: Proxy filing

2026-03-13T20:30:19.000Z - 6 months ago

Stereotaxis files $100M mixed securities shelf

2026-03-13T19:35:41.000Z - 6 months ago

Stereotaxis management to meet virtually with BTIG

Mar 13, 2026, 8:00 AM EDT - 6 months ago

Stereotaxis Registration statement: Registration Filing

Mar 9, 2026, 4:30 PM EDT - 6 months ago

Stereotaxis Earnings Call Transcript: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 6 months ago

Stereotaxis Annual report: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 6 months ago

Stereotaxis Earnings release: Q4 2025

2026-03-09T20:05:19.000Z - 6 months ago

Stereotaxis reports Q4 EPS (6c), consensus (6c)

2026-03-09T20:05:10.000Z - 6 months ago

Stereotaxis sees FY26 revenue up double digits

Mar 9, 2026, 4:01 PM EDT - 6 months ago

Stereotaxis Reports 2025 Full Year Financial Results

Feb 12, 2026, 9:00 AM EST - 7 months ago

Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026

2026-02-09T13:37:08.000Z - 7 months ago

Stereotaxis announces launch of electrophysiology program at Klinikum Furth

Feb 9, 2026, 8:06 AM EST - 7 months ago

Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program

2026-01-06T13:39:16.000Z - 8 months ago

Stereotaxis reports FDA approval for MAGiC Ablation Catheter

Jan 6, 2026, 8:01 AM EST - 8 months ago

Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

2025-12-16T09:40:34.000Z - 9 months ago

Stereotaxis initiated with an Outperform at Citizens

Nov 24, 2025, 8:58 AM EST - 9 months ago

Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference

Nov 11, 2025, 4:30 PM EST - 10 months ago

Stereotaxis Earnings Call Transcript: Q3 2025

Nov 11, 2025, 4:30 PM EST - 10 months ago

Stereotaxis Quarterly report: Q3 2025

Nov 11, 2025, 4:30 PM EST - 10 months ago

Stereotaxis Earnings release: Q3 2025

2025-11-11T21:05:25.000Z - 10 months ago

Stereotaxis reports Q3 EPS (7c), consensus (6c)

Nov 11, 2025, 4:01 PM EST - 10 months ago

Stereotaxis Reports 2025 Third Quarter Financial Results

2025-11-10T22:01:01.000Z - 10 months ago

Stereotaxis announces FDA clearance for GenesisX

Nov 10, 2025, 4:05 PM EST - 10 months ago

GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance

Oct 21, 2025, 9:00 AM EDT - 11 months ago

Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025

Oct 15, 2025, 7:32 AM EDT - 11 months ago

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs

Oct 13, 2025, 7:34 AM EDT - 11 months ago

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias

Sep 22, 2025, 7:56 AM EDT - 12 months ago

Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System

Sep 2, 2025, 8:08 AM EDT - 1 year ago

First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter

Sep 2, 2025, 7:51 AM EDT - 1 year ago

Stereotaxis to Present at Upcoming Investor Conferences

Aug 28, 2025, 7:47 AM EDT - 1 year ago

Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Earnings release: Q2 2025

Aug 7, 2025, 4:01 PM EDT - 1 year ago

Stereotaxis Reports 2025 Second Quarter Financial Results

Jul 28, 2025, 7:48 AM EDT - 1 year ago

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

Jul 23, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 17, 2025, 8:32 AM EDT - 1 year ago

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock

Jul 1, 2025, 9:00 AM EDT - 1 year ago

First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

May 12, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Earnings Call Transcript: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Quarterly report: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Earnings release: Q1 2025

May 12, 2025, 4:01 PM EDT - 1 year ago

Stereotaxis Reports 2025 First Quarter Financial Results

Apr 22, 2025, 7:00 AM EDT - 1 year ago

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

Apr 21, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis Proxy statement: Proxy Filing

Mar 19, 2025, 8:01 AM EDT - 1 year ago

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program

Mar 10, 2025, 8:02 AM EDT - 1 year ago

Stereotaxis to Present at 37th Annual Roth Conference

Mar 3, 2025, 8:30 AM EST - 1 year ago

Stereotaxis Earnings Call Transcript: Q4 2024

Mar 3, 2025, 8:30 AM EST - 1 year ago

Stereotaxis Annual report: Q4 2024

Mar 3, 2025, 8:30 AM EST - 1 year ago

Stereotaxis Earnings release: Q4 2024

Mar 3, 2025, 7:32 AM EST - 1 year ago

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

Mar 3, 2025, 7:31 AM EST - 1 year ago

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance

Mar 3, 2025, 7:30 AM EST - 1 year ago

Stereotaxis Reports 2024 Full Year Financial Results

Feb 25, 2025, 8:03 AM EST - 1 year ago

Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference

Feb 3, 2025, 4:05 PM EST - 1 year ago

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Jan 30, 2025, 8:09 AM EST - 1 year ago

Stereotaxis Announces First GenesisX Robotic System Order

Jan 27, 2025, 8:00 AM EST - 1 year ago

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

Jan 14, 2025, 7:21 AM EST - 1 year ago

Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology

Dec 9, 2024, 7:25 AM EST - 1 year ago

Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA

Dec 2, 2024, 8:45 AM EST - 1 year ago

Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems

Nov 26, 2024, 8:28 AM EST - 1 year ago

Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference

Nov 25, 2024, 8:21 AM EST - 1 year ago

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China

Nov 20, 2024, 8:18 AM EST - 1 year ago

Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System

Nov 11, 2024, 4:30 PM EST - 1 year ago

Stereotaxis Earnings Call Transcript: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Stereotaxis Quarterly report: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Stereotaxis Earnings release: Q3 2024

Nov 11, 2024, 4:02 PM EST - 1 year ago

Stereotaxis Reports 2024 Third Quarter Financial Results

Oct 21, 2024, 8:41 AM EDT - 1 year ago

Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

brunoq14 Sep. 17 at 10:05 PM

$STXS At this rate if they ever report some decent sales the price might double.

0 · Reply

Eddypgil Sep. 17 at 12:33 PM

$STXS company has long awaited products, steadily growing revenue, cash in bank. It shouldn’t be trading for a $1.33! Market cap is $132 million.

0 · Reply

brunoq14 Sep. 16 at 4:55 PM

$STXS https://ir.stereotaxis.com/news-releases/news-release-details/stereotaxis-emerging-digital-ai-and-automation-capabilities-be

1 · Reply

TAE63 Sep. 16 at 1:10 PM

Liking $STXS , this week .

1 · Reply

Eddypgil Sep. 15 at 12:27 PM

$STXS too much going on with company to be at $1.33. The recent purchase of the French company behind price decline most likely

0 · Reply

PatVian Sep. 11 at 4:32 PM

$STXS Love the tech and potential. They are working on the catheter bottleneck as well. Could be explosive eventually, especially if upcoming data is strong 💪🏼

0 · Reply

Eddypgil Sep. 11 at 2:49 PM

$STXS they have a leasing program for GenesisX . No buildout needed. One would think they’d sell at least a half dozen in this quarter

0 · Reply

dman6 Sep. 11 at 12:49 AM

$STXS is there anyone here?? Zero chatter on this ticker

2 · Reply

Eddypgil Sep. 10 at 9:18 PM

$STXS does company have a talented sales team? They seem to have had great products approved over past year and few Genesis sales.

0 · Reply

Eddypgil Sep. 8 at 3:57 PM

$STXS ceo wouldn’t have made the acquisition of Robocath if he didn’t see strong future business in the pipeline. This could be a great time to buy possibly. First quarter sales could surprise

0 · Reply

Eddypgil Sep. 7 at 12:54 PM

$STXS company has the silliest name. Everything is in place. Time to change the company name to Robocath!

1 · Reply

brunoq14 Sep. 4 at 2:40 PM

$STXS https://ir.stereotaxis.com/news-releases/news-release-details/university-szeged-celebrates-strongest-first-month-robotic

2 · Reply

Eddypgil Sep. 4 at 1:29 PM

$STXS I think it’s time for a name change. They just merged with Robocath. The combined company should adopt that name. I recall when cnbc announced the company was ringing the bell the day they moved to the new exchange they couldn’t even say the name

0 · Reply

DecoderRing Sep. 4 at 11:17 AM

$STXS Makes zero sense to have an installation doing 70 procedures a month when they can't even make 100 catheters a month for the entire world?

2 · Reply

Eddypgil Sep. 3 at 1:35 PM

$STXS I’ve been seeing more Genesis adoption in Europe . That’s probably why the merged with Robocath

1 · Reply

Apep214 Sep. 3 at 12:35 PM

$STXS 70 procedures within a month at University of Szeged with a Genesis system.

1 · Reply

Eddypgil Sep. 3 at 11:59 AM

$STXS might be time to change company’s name to Robocath.

1 · Reply

Eddypgil Sep. 1 at 5:08 PM

$STXS probably not a good time to make an acquisition. Sell the new products and drive the catheter business while preserving cash.

1 · Reply

Eddypgil Aug. 27 at 5:23 PM

$STXS I sure hope they start producing 2000 magic catheters a month by next year. No one will buy a GenesisX if they can’t get their hands on catheters

1 · Reply

alexpitti Aug. 27 at 4:37 AM

$STXS you know things are bad in 2026 when we are excited about 2 pennies

0 · Reply

Forenzi Aug. 27 at 3:26 AM

$STXS under accumulation! You can just feel it. They tried to hit it at the close and play the mean reversion game but in the last couple of minutes the volume increased and it closed .02 cents higher . Wow you can say facetiously but sensing something subtle going on after the huge Kaufman stake was announced.

1 · Reply

no_ego Aug. 24 at 7:46 PM

$STXS downgrades hurt

0 · Reply

Market Cap	132.27M
Revenue (ttm)	32.38M
Net Income (ttm)	-21.64M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-66.83%
Debt to Equity Ratio	0.00

Volume	598,350
Avg Vol	896,586
Day's Range	N/A - N/A
Shares Out	100.20M
Stochastic %K	17%
Beta	1.43
Analysts	Strong Sell
Price Target	$3.00